MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. MyOme leverages the power of the whole genome for a lifetime of actionable insights. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in Menlo Park, California.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/21/22 | $23,000,000 | Series B |
Healthcare Venture Partners Natera SoftBank Capital | undisclosed |
